Therapeutic potential of PKC inhibitors in painful diabetic neuropathy

Author： Kamei Junzo   Mizoguchi Hirokazu   Narita Minoru   Tseng Leon F  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.9, 2001-09, pp. : 1653-1664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mexiletine: A Review of its Therapeutic Use in Painful Diabetic Neuropathy

By Jarvis B.   Coukell A.J.  

Drugs, Vol. 56, Iss. 4, 1998-10 ,pp. : 691-707

Adis International

Access to resources Recommend Favorite

Voltage-Gated Sodium Channels as Therapeutic Targets for Treatment of Painful Diabetic Neuropathy

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 14, 2015-12 ,pp. : 1134-1147

Bentham Science Publishers

Access to resources Recommend Favorite

The Potential Role of Angiotensin Converting Enzyme and Vasopeptidase Inhibitors in the Treatment of Diabetic Neuropathy

By  

Current Drug Targets, Vol. 9, Iss. 1, 2008-01 ,pp. : 77-84

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclooxygenase-2 Pathway as a Potential Therapeutic Target in Diabetic Peripheral Neuropathy

By  

Current Drug Targets, Vol. 9, Iss. 1, 2008-01 ,pp. : 68-76

Bentham Science Publishers

Access to resources Recommend Favorite

Still the status quo for painful diabetic neuropathy

By  

Inpharma, Vol. 1, Iss. 1593, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite